###begin article-title 0
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PRP17</italic>
Dependence of pre-mRNA introns on PRP17, a non-essential splicing factor: implications for efficient progression through cell cycle transitions
###end article-title 0
###begin p 1
###xml 99 121 99 121 <email xmlns:xlink="http://www.w3.org/1999/xlink">uvr@mcbl.iisc.ernet.in</email>
To whom correspondence should be addressed. Tel: +11 91 80 3600168; Fax: +11 91 80 3602697; Email: uvr@mcbl.iisc.ernet.in
###end p 1
###begin p 2
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae PRP17</italic>
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC40</italic>
###xml 269 270 269 270 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 278 279 278 279 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 312 313 312 313 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 327 338 327 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 428 432 428 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN1</italic>
###xml 434 438 434 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLB5</italic>
###xml 443 447 443 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNR1</italic>
###xml 628 633 624 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 662 663 658 659 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 686 690 682 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 695 699 691 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 757 762 749 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 801 805 793 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 833 838 825 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 840 845 832 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp16</italic>
###xml 850 855 842 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp22</italic>
###xml 884 889 876 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp18</italic>
###xml 891 897 883 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink">slu7-1</italic>
###xml 902 908 894 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">psf1-1</italic>
###xml 910 914 902 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 947 955 939 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 970 974 962 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 1026 1037 1018 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 1148 1152 1140 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 1194 1199 1186 1191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 1385 1386 1377 1378 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1394 1395 1386 1387 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 0 24 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Saccharomyces cerevisiae PRP17 (CDC40) encodes a second-step pre-mRNA splicing factor with a role in cell division. The functions of Prp17 in specific cell cycle transitions were examined using temperature-sensitive alleles in arrest/release experiments. We find that G1/S and G2/M transitions depend on Prp17. G1-synchronized prp17::LEU2 cells arrest at non-permissive temperatures as unbudded haploid cells with low levels of CLN1, CLB5 and RNR1 transcripts. This indicates a Prp17 execution point at or prior to Start. Reduced levels of alpha-tubulin protein, a mitotic spindle component, underlie the benomyl sensitivity of prp17 mutants and possibly their G2/M arrest. Splicing of TUB1 and TUB3 transcripts, which encode alpha-tubulin, was analyzed in prp17 and other second-step factor mutants. TUB1 splicing is inefficient in prp17, prp16 and prp22, and marginally affected in prp18, slu7-1 and psf1-1. TUB3 splicing is similarly affected. In vitro splicing with TUB3 pre-mRNA demonstrates a compromised second step in prp17::LEU2 extracts, implicating a direct role for Prp17 in its efficient splicing. Genomic replacement of an intronless TUB1 gene relieves the benomyl sensitivity of prp17 mutants; however, they remain temperature sensitive, implying multiple limiting factors for mitosis. The data suggest that integration of splicing with the cell cycle is important for G1/S and G2/M transitions.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 147 171 147 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 408 409 408 409 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 414 415 414 415 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 425 426 425 426 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1240 1241 1240 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c1">1</xref>
###xml 1242 1243 1242 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c6">6</xref>
###xml 147 171 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 1185 1199 <span type="species:ncbi:4896">fission yeasts</span>
###xml 1227 1232 <span type="species:ncbi:9606">human</span>
In eukaryotic cells, an orderly progression through the mitotic cycle is ensured by the highly regulated transition from one phase to the next. In Saccharomyces cerevisiae, as in other eukaryotes, a number of evolutionarily conserved effectors, such as the p34-cyclin-dependent protein kinase Cdc28/Cdc2, play a critical role in driving the division cycle. The movement across major cell cycle transitions (G1/S, G2/M and M/G1) is controlled by timed activation/inactivation of these specific effectors, many of which are very well studied. Cells also use the general cellular/metabolic processes for efficient regulation of cell cycle events. For example, although the ubiquitous 26S proteasome degrades all ubiquitin-tagged proteins, its activity is harnessed by specific ubiquitin ligases (E3 enzymes) to degrade cell cycle phase-dependent substrates. Such regulatory controls exemplify how the general cellular machinery for protein degradation, though not particularly specialized for cell cycle control, is utilized to drive the cell cycle with critical specificity. Although links between the cell cycle and RNA processing events are indicated by genetic studies in budding and fission yeasts and biochemical studies in human cells (1-6), they have not been investigated thoroughly.
###end p 4
###begin p 5
###xml 112 123 112 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PRP17/CDC40</italic>
###xml 125 130 125 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PRP17</italic>
###xml 199 200 199 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c7">7</xref>
###xml 214 221 214 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc40-1</italic>
###xml 314 315 314 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c7">7</xref>
###xml 316 317 316 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c8">8</xref>
###xml 396 397 396 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c9">9</xref>
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c10">10</xref>
###xml 429 434 429 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PRP17</italic>
###xml 439 444 439 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC40</italic>
###xml 477 484 477 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo</italic>
###xml 539 547 539 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 569 573 569 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACT1</italic>
###xml 670 671 670 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c9">9</xref>
###xml 672 674 672 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c11">11</xref>
###xml 675 677 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c12">12</xref>
###xml 751 753 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c13">13</xref>
###xml 754 756 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c14">14</xref>
###xml 809 820 809 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 828 833 828 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PRP17</italic>
###xml 914 919 914 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PRP18</italic>
###xml 921 926 921 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PRP16</italic>
###xml 928 932 928 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLU7</italic>
###xml 934 938 934 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PRP8</italic>
###xml 940 945 940 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PRP22</italic>
###xml 970 971 970 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c4">4</xref>
###xml 972 974 972 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c10">10</xref>
###xml 975 977 975 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c11">11</xref>
###xml 978 980 978 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c15">15</xref>
###xml 981 983 981 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c16">16</xref>
###xml 1008 1013 1008 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PRP18</italic>
###xml 730 735 <span type="species:ncbi:9606">human</span>
###xml 803 808 <span type="species:ncbi:4932">yeast</span>
In this report, we have investigated the connections between cell division and splicing with a special focus on PRP17/CDC40. PRP17 encodes a protein essential for viability at elevated temperatures (7). Studies on cdc40-1 and a null allele showed a role in both initiation of DNA replication and nuclear division (7,8). Independent genetic screens identified Prp17 as a pre-mRNA splicing factor (9,10). Sequence identity between PRP17 and CDC40 shows them to be the same gene. In vivo analysis of several intron-containing transcripts and in vitro experiments with the ACT1 pre-mRNA implicate a role for Prp17 in the second transesterification reaction during splicing (9,11,12). This function is apparently conserved even in the human Prp17 protein (13,14) that partially complements growth defects of yeast prp17::LEU2. While PRP17 is not essential for viability, it exhibits extensive genetic interactions with PRP18, PRP16, SLU7, PRP8, PRP22, U5 snRNA and U2 snRNA (4,10,11,15,16). With the exception of PRP18, all the others are essential for the second step of splicing.
###end p 5
###begin p 6
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp3</italic>
###xml 96 102 96 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dbf3-1</italic>
###xml 108 112 108 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp8</italic>
###xml 120 124 120 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dbf5</italic>
###xml 140 145 140 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp22</italic>
###xml 150 154 150 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cef1</italic>
###xml 200 201 200 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c1">1</xref>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c17">17</xref>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c18">18</xref>
###xml 236 247 236 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17/cdc40</italic>
###xml 329 330 329 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c7">7</xref>
###xml 487 492 487 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 634 635 634 635 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 643 644 643 644 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 771 775 767 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 780 784 776 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 845 850 841 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 1019 1023 1015 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 1057 1065 1053 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 34 39 <span type="species:ncbi:4932">yeast</span>
In addition to Prp17, a few other yeast splicing factors affect the cell cycle. The prp3 allele dbf3-1, the prp8 allele dbf5 and alleles of prp22 and cef1 were uncovered in cell cycle mutant screens (1,17,18). The diverse phenotypes of prp17/cdc40-null cells hint that Prp17 influences more than one stage in the division cycle (7). This prompted us to examine the role of Prp17 closely in specific events of the division cycle. Using different temperature-sensitive missense alleles of prp17 in various arrest/release protocols, we have assessed the execution points for this splicing factor. We show that Prp17 is required for the G1/S and G2/M transitions. The latter requirement is due in part to the highly compromised splicing of alpha-tubulin transcripts from the TUB1 and TUB3 genes, which contain non-standard introns. This analysis in prp17 and in several second-step splicing factor mutants demonstrates a differential dependence of these cellular RNAs on some splicing factors. The contribution of Prp17 to TUB3 intron splicing was also studied in vitro. We find an inefficient second step even in wild-type extracts, a defect exacerbated in the absence of Prp17. Altogether, our data suggest a role for a non-essential pre-mRNA splicing factor in efficient progression through cell cycle transitions.
###end p 6
###begin title 7
MATERIALS AND METHODS
###end title 7
###begin title 8
Strains
###end title 8
###begin p 9
###xml 15 45 11 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MATa prp17::LEU2 ade2-101 his3</italic>
###xml 50 106 42 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">200 ura3-52 lys2 trp1 leu2-3 leu2-112 bar1::hisGURA3hisG</italic>
###xml 133 150 125 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-1 bar::URA3</italic>
###xml 158 184 150 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MATa prp17-1 ade2-101 his3</italic>
###xml 189 224 177 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">200 ura3-52 lys2 bar1::hisGURA3hisG</italic>
###xml 226 243 214 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-2 bar::URA3</italic>
###xml 251 268 239 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MATa prp17-2 his3</italic>
###xml 273 307 257 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">200 ura3-52 trp bar1::hisGURA3hisG</italic>
###xml 309 316 293 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-3</italic>
###xml 324 341 308 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MATa ura3-52 his3</italic>
###xml 346 354 326 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">200 trp1</italic>
###xml 359 384 335 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">63 lys2-801 ade2-101 leu2</italic>
###xml 389 390 361 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 392 398 364 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">slu7-1</italic>
###xml 403 409 375 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">psf1-1</italic>
###xml 470 477 442 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-4</italic>
###xml 486 505 458 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MATa cdc40 ade2-128</italic>
YPH274Delta17a MATa prp17::LEU2 ade2-101 his3Delta200 ura3-52 lys2 trp1 leu2-3 leu2-112 bar1::hisGURA3hisG was the null allele used. prp17-1 bar::URA3 strain MATa prp17-1 ade2-101 his3Delta200 ura3-52 lys2 bar1::hisGURA3hisG. prp17-2 bar::URA3 strain MATa prp17-2 his3Delta200 ura3-52 trp bar1::hisGURA3hisG. prp17-3 strain MATa ura3-52 his3Delta200 trp1Delta63 lys2-801 ade2-101 leu2Delta1; slu7-1 and psf1-1 strains were obtained from C. Guthrie, UCSF, San Francisco. prp17-4 (AAY80) MATa cdc40 ade2-128 was obtained from A. E. M. Adams, University of Arizona, Tucson. The permissive temperature for all strains was 23degreesC and the restrictive temperature was 37degreesC.
###end p 9
###begin title 10
Synchronization procedures and flow cytometry analysis
###end title 10
###begin p 11
###xml 5 6 5 6 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 36 37 36 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 101 102 93 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 160 161 144 145 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 472 474 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c19">19</xref>
For G1 arrest, cells grown to 1 x 107cells/ml were treated with alpha-factor (1.0 microg/ml). For BAR+ strains, 5 microg/ml alpha-factor was added. After >95% G1 arrest, the cells were filtered, washed and inoculated into fresh media kept at 23 or 37degreesC. For early S phase growth arrest, hydroxyurea (15 mg/ml) was added to the cultures. After 3 h, the synchronized cells were treated as mentioned above. Flow cytometry analysis of DNA content was done as described (19).
###end p 11
###begin title 12
Immunofluorescence analysis
###end title 12
###begin p 13
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c20">20</xref>
###xml 187 193 <span type="species:ncbi:9913">bovine</span>
###xml 292 296 <span type="species:ncbi:9925">goat</span>
###xml 302 305 <span type="species:ncbi:10116">rat</span>
Indirect immunofluorescence of the mitotic spindle and 4',6-diamidino-2-phenylindole staining of the nuclei were performed as described (20). The primary antibody was YOL134 (1:500 in 1% bovine serum albumin-phosphate-buffered saline) and tetramethylrhodamine isothiocyanate TRITC-conjugated goat anti-rat sera (1:30 dilution, Jackson Immunoresearch Company) were the secondary antibodies. Cells were observed on a Zeiss Axioscope microscope and images captured on Axiocam (Zeiss).
###end p 13
###begin title 14
Preparation of total RNA and RT-PCR analysis
###end title 14
###begin p 15
###xml 133 134 127 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c9">9</xref>
###xml 314 318 300 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 323 327 309 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 329 333 315 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 377 381 363 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 549 553 523 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 615 619 589 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 631 635 605 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 698 702 672 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 798 802 772 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 837 841 811 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 885 889 859 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
Cells from early-mid log phase cultures were collected either before or after growth at 37degreesC for 1 h. Total RNA was extracted (9) and 5-10 microg used to make first-strand cDNA using SuperscriptII (Invitrogen) in a 20 microl reaction. Gene-specific primers for reverse transcription were chosen in exon 2 of TUB1 and TUB3: TUB3 exon 2 primer (5'-CTCTTGCGTAGTTATTGGC-3'); TUB1 exon 2 primer (5'-CCTATCCAGAACATCGCCCAA-3'). A 3 microl aliquot from each reverse transcriptase reaction was used in a 15 microl PCR with 1 microM exon 2 primer and a TUB3-specific exon 1 primer (5'-AGAGAGGTCATTAGTATT-3') to amplify TUB3 cDNA, or a TUB1-specific exon 1 primer (5'-GAGAGAAGTTATTAGTATT-3') to amplify TUB1 cDNA. Twenty-five PCR cycles were done for a linear response. The expected RT-PCR product from TUB3 pre-mRNA is 614 bp, and that from TUB3 mRNA is 316 bp. The predicted product from TUB1 pre-mRNA is 481 bp and from its mRNA is 366 bp. As controls for these reactions, U5 snRNA levels were measured using primers U5RT RP (5'-AACGCCCTCCTTACTCATTG-3') and U5 RT FP (5'-GCAGCTTTACAGATCAAT-3'). All PCR products were resolved on 10% native PAGE gels. Photostimulated luminescence counts were obtained in a phosphorimager.
###end p 15
###begin title 16
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN2</italic>
###xml 61 72 61 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
Construction of a strain for inducible expression of CLN2 in prp17::LEU2 cells
###end title 16
###begin p 17
###xml 38 39 38 39 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 49 57 49 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL-CLN2</italic>
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3</italic>
###xml 124 128 124 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3</italic>
###xml 167 170 167 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar</italic>
###xml 191 196 191 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 201 226 197 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YPH274 bar:hisg:URA3:hisg</italic>
###xml 293 294 289 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 302 303 298 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 340 343 336 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stu</italic>
###xml 356 364 352 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL-CLN2</italic>
###xml 500 504 496 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN2</italic>
A galactose-inducible version of the G1 cyclin, pGAL-CLN2, was integrated at the URA3 locus. Prior to this integration, the URA3 cassette previously integrated at the bar locus in the strain prp17DeltaYPH274 bar:hisg:URA3:hisg was excised by selection on 5-fluoro-orotic acid media. Single bar- and ura- colonies were then transformed with StuI-linearized GAL-CLN2 (pUS152) construct. The integrants were verified by Southern analysis, and northern analysis confirmed galactose-induced expression of CLN2.
###end p 17
###begin title 18
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
In vitro transcription and splicing
###end title 18
###begin p 19
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c21">21</xref>
###xml 232 235 232 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Acc</italic>
###xml 250 258 250 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 301 305 301 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c21">21</xref>
###xml 475 478 475 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sna</italic>
###xml 521 525 521 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACT1</italic>
###xml 554 557 554 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 577 579 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c22">22</xref>
###xml 582 590 582 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 652 654 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c23">23</xref>
###xml 759 763 759 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 823 827 823 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACT1</italic>
The TUB1 minigene construct was generated by PCR amplification of residues +3 to +1028 of the open reading frame (ORF) present in the plasmid RB306 (21). The product, cloned in the PCR blunt vector (Invitrogen), was linearized with AccI and used for in vitro transcription with T7 RNA polymerase. The TUB3 minigene construct was generated by PCR of +3 to +617 bp of the ORF in RB300 (21). The product was cloned in the pBluescript vector. The recombinant was linearized with SnaBI and transcribed with T7 RNA polymerase. ACT1 substrate was prepared from BamHI-linearized p422 (22). In vitro transcription and splicing reactions were done as described (23). The splicing reactions were resolved on 8.5% (19:1) denaturing polyacrylamide gels for reactions with TUB3 transcripts; 6.5% (19:1) gels were used for reactions with ACT1. Quantitations were done by phosphorimager analysis.
###end p 19
###begin title 20
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
Construction and homologous replacement of an intronless TUB1 gene
###end title 20
###begin p 21
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 145 149 145 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 312 316 312 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c21">21</xref>
###xml 395 399 395 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 440 443 436 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sal</italic>
###xml 445 448 441 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cla</italic>
###xml 465 469 461 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 552 554 544 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bs</italic>
###xml 330 335 <span type="species:ncbi:4932">yeast</span>
###xml 600 605 <span type="species:ncbi:4932">yeast</span>
A 74 nt primer starting 26 bp upstream of the TUB1 ATG, spanning exon 1 and creating a translational fusion to exon 2, was made. In a PCR with a TUB1 exon 2 reverse primer, this 76mer would delete the intron. The PCR product was cloned and sequenced. This intronless DNA fragment was then swapped with wild-type TUB1 present in a yeast centromeric vector pRB326 (21) to create the recombinant: pTUB1Deltai RB326. For genomic integration, a SalI-ClaI fragment from pTUB1Deltai RB326 was cloned in pRS303. The resultant recombinant was linearized at the BstEII site in exon 2 before integration in the yeast genome.
###end p 21
###begin title 22
RESULTS
###end title 22
###begin title 23
###xml 27 28 27 28 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
Prp17 is required for the G1/S transition of the cell cycle
###end title 23
###begin p 24
###xml 93 98 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 357 358 345 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f1">1</xref>
To examine the role of Prp17 in the cell cycle, an asynchronous population of cells with the prp17 null allele were grown at 23degreesC and then transferred to the restrictive temperature (37degreesC). By fluorescence-activated cell sorting (FACS) analysis, we note that there are only minimal changes in the DNA content of these cells even after 5 h (Fig. 1A). At 37degreesC, the culture contained two populations of cells: approximately40% with 1N DNA content and approximately60% with 2N DNA content. This suggests that Prp17 plays a role at two stages of the division cycle.
###end p 24
###begin p 25
###xml 89 95 89 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PRP17,</italic>
###xml 108 113 108 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 197 204 197 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-1</italic>
###xml 206 213 206 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-2</italic>
###xml 215 222 215 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-3</italic>
###xml 224 231 224 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-4</italic>
###xml 236 247 236 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 292 299 292 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-1</italic>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c11">11</xref>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c16">16</xref>
###xml 437 438 437 438 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 703 714 703 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 879 880 879 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f1">1</xref>
###xml 888 895 888 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-4</italic>
###xml 928 929 928 929 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 946 947 946 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkg333tb1">1</xref>
###xml 1052 1057 1052 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PRP17</italic>
###xml 1092 1099 1092 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-1</italic>
###xml 1191 1192 1187 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkg333tb1">1</xref>
###xml 1214 1221 1210 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-2</italic>
###xml 1335 1336 1331 1332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkg333tb1">1</xref>
###xml 1342 1349 1338 1345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-2</italic>
###xml 1594 1595 1590 1591 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1632 1639 1628 1635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-1</italic>
###xml 1701 1702 1697 1698 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
To confirm these observations, and to aid in clearly defining the execution point(s) for PRP17, a number of prp17 alleles were studied in various arrest/release protocols. The alleles chosen were: prp17-1, prp17-2, prp17-3, prp17-4 and prp17::LEU2, the null allele. It is noteworthy that the prp17-1 mutation, an allele analyzed in detail here, lies in the N-terminal region of the protein that is functionally important (11,16). After G1 synchronization, cells were allowed to re-enter the division cycle at either permissive or non-permissive temperatures. Cellular DNA content was monitored and the status of the mitotic spindle assessed during cell cycle progression. At the permissive temperature, prp17::LEU2 cells grow slowly, enter S phase and subsequently complete mitosis. However, at non-permissive temperatures, these cells arrest uniformly with 1N DNA content (Fig. 1B). The prp17-4 allele also confers a complete G1/S arrest (Table 1). This implicates a requirement for Prp17 during transition to S phase. Interestingly, other alleles of PRP17 behave differently. For instance, prp17-1 cells after release from alpha-factor synchronization completely arrest with 2N DNA (Table 1). On the other hand, prp17-2 causes predominantly a 1N arrest with only a small proportion of cells progressing slowly through S phase (Table 1). In prp17-2, the mutation lies in the nuclear localization signal, which could retard nuclear trafficking of this protein and cause slow progression through S phase. We conclude, therefore, that at least one execution point for Prp17/Cdc40 is in the late G1 phase. However, the behavior of the prp17-1 mutant raises the possibility of a stringent requirement at G2/M.
###end p 25
###begin title 26
Prp17 is required in the pre-Start phase of the cell cycle
###end title 26
###begin p 27
###xml 47 48 47 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 79 80 79 80 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 90 95 90 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 283 284 283 284 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c24">24</xref>
###xml 513 515 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c25">25</xref>
###xml 564 568 564 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLB5</italic>
###xml 593 594 593 594 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 608 619 608 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 691 695 691 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLB5</italic>
###xml 866 867 866 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f2">2</xref>
###xml 871 882 871 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 929 933 923 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLB5</italic>
###xml 1045 1046 1035 1036 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1065 1069 1049 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLB5</italic>
###xml 1151 1152 1135 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f2">2</xref>
###xml 1286 1297 1270 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 1365 1369 1349 1353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNR1</italic>
###xml 1519 1523 1503 1507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNR1</italic>
###xml 1625 1630 1609 1614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 1651 1652 1629 1630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f2">2</xref>
###xml 1701 1702 1679 1680 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1710 1714 1688 1692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN1</italic>
###xml 1789 1793 1767 1771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN1</italic>
###xml 1804 1809 1782 1787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 1939 1940 1905 1906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f2">2</xref>
###xml 1995 2000 1961 1966 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 2044 2045 2010 2011 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
To define better the function of Prp17 during G1/S, we analyzed the window in G1 at which prp17 cells are arrested. More specifically, we asked if in the absence of Prp17 the cells pass through Start and arrest at a post-Start phase. Traditionally, Start is defined as the point in G1 beyond which cells are irreversibly committed to a new division cycle. The emergence of a bud, a burst of transcription of specific genes and initiation of DNA replication are some of the major indicators of this commitment (24,25). We analyzed the Start-dependent expression of CLB5, an S-phase cyclin, in G1-synchronized prp17::LEU2 cells that resume growth at permissive or non-permissive temperatures. CLB5 transcript levels were determined 30 min after release from synchronization. The analysis was repeated in culture aliquots withdrawn at subsequent hourly intervals (Fig. 2A). prp17::LEU2 cells at 23degreesC accumulate high levels of CLB5 within 2 h of release from alpha-factor treatment and, by 4 h, the levels decline, indicating passage through G1/S. At 37degreesC, CLB5 RNA levels do not build up even 5 h after the release from synchronization (Fig. 2A). These data are consistent with the absence in this culture of cells with 2N DNA content. To establish the pre-Start arrest in the prp17::LEU2, a second marker for early S phase was employed. The expression of RNR1, encoding ribonucleotide reductase, is transcriptionally activated in a Start-dependent manner, since high levels of Rnr1 are necessary for S phase. RNR1 transcript levels in the same experimental set-up as described above show no significant increase in prp17 at 37degreesC (Fig. 2B). Additionally, we assessed the levels of the G1 cyclin CLN1, transcriptional upregulation of which is a prerequisite for Start. While CLN1 levels in prp17 cells at 23degreesC reach a peak within 30 min of release from synchronization, this increase fails to occur at 37degreesC (Fig. 2C). Together, the data confirm the pre-Start arrest in prp17 cells and suggest a role for Prp17 in the G1/S window lying between alpha-factor arrest and Start.
###end p 27
###begin title 28
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN2</italic>
###xml 60 61 60 61 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 73 84 73 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
Ectopic induced transcription of CLN2 does not relieve the G1/S block in prp17::LEU2 cells
###end title 28
###begin p 29
###xml 42 43 42 43 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 88 99 88 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 297 301 297 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN2</italic>
###xml 397 401 397 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN2</italic>
###xml 447 451 447 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN2</italic>
###xml 484 488 484 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3</italic>
###xml 498 509 498 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 645 654 639 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1-CLN2</italic>
###xml 815 819 805 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN2</italic>
###xml 906 907 892 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f3">3</xref>
###xml 1162 1163 1138 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f3">3</xref>
###xml 1189 1193 1165 1169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN2</italic>
###xml 1239 1240 1215 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f3">3</xref>
###xml 1384 1388 1348 1352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN2</italic>
###xml 1446 1447 1410 1411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f3">3</xref>
###xml 1477 1488 1441 1452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 1527 1531 1491 1495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN2</italic>
###xml 1647 1648 1605 1606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f3">3</xref>
###xml 1703 1707 1661 1665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN2</italic>
###xml 1712 1713 1670 1671 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1806 1807 1764 1765 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1820 1831 1778 1789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 1900 1904 1858 1862 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN2</italic>
###xml 2055 2056 2013 2014 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 2110 2121 2068 2079 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
The failure to accumulate high levels of G1 cyclins could cause the pre-Start arrest in prp17::LEU2 cells. To understand if this is the sole defect in these cells and that there are no other regulatory controls, we have analyzed the consequences of ectopic induction of the functionally redundant CLN2 gene in these arrested cells. A construct where a galactose-inducible transcription control of CLN2 can be obtained was employed. This regulated CLN2 construct was integrated at the URA3 locus of prp17::LEU2 (Materials and Methods) and then used in cell cycle protocols. Such cells grown at 23degreesC with raffinose as the carbon source keep GAL1-CLN2 repressed and were synchronized with alpha-factor. At 1.5 h before complete synchronization of cells was achieved, galactose was added to the culture to induce CLN2 transcription, but cells were kept arrested due to the presence of alpha-factor (Fig. 3A). After complete synchronization, the cells were moved into alpha-factor-free medium containing either raffinose in the control sample or galactose in the experimental set-up. Both control and experimental cultures were grown at 23 and 37degreesC (Fig. 3A). Cells maintained in a CLN2-repressed state (i.e. raffinose medium, Fig. 3B, top left) at 23degreesC grow slowly yet pass through Start and complete DNA synthesis by 4 h. As expected, at 37degreesC these cells without CLN2 overexpression remain arrested with 1N DNA content (Fig. 3B, top right), reflecting the prp17::LEU2 phenotype. Notably, in cultures where CLN2 is induced (galactose), the cells do not pass through Start and fail to complete DNA synthesis at 37degreesC (Fig. 3B, bottom right). Thus, we find that overexpression of CLN2, a G1 cyclin whose levels are a determinant for passage through Start, cannot compensate for the G1/S arrest in prp17::LEU2 cells at non-permissive temperature. It is highly unlikely that the CLN2 transcript is a direct target for Prp17 as it lacks introns. These data point to multiple targets for Prp17 and indicate that the pathway leading to G1 cyclin expression is not the only limiting factor in prp17::LEU2 cells.
###end p 29
###begin title 30
###xml 1 2 1 2 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
G2/M transition defines the second point of Prp17 requirement
###end title 30
###begin p 31
###xml 26 27 26 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 40 47 40 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-1</italic>
###xml 99 100 99 100 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 155 156 155 156 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 171 176 171 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 179 183 179 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEU2</italic>
###xml 293 294 293 294 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 390 401 384 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 505 506 499 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f1">1</xref>
###xml 593 594 587 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f1">1</xref>
###xml 697 702 691 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 710 711 704 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkg333tb1">1</xref>
###xml 735 740 729 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 957 968 951 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 997 998 991 992 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1448 1459 1438 1449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 1530 1531 1520 1521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f1">1</xref>
###xml 1630 1631 1620 1621 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1639 1640 1629 1630 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Prompted by the complete G2/M arrest of prp17-1, we next examined if the alleles causing a strict G1/S arrest are also defective for the temporally later G2/M transition. prp17:: LEU2 cells were synchronized in early S phase by hydroxyurea (HU) treatment so that they were already past their G1/S execution point. Subsequently, cell cycle progression was monitored at 23 and 37degreesC. In prp17::LEU2 cells released at permissive temperature, DNA was replicated by 2 h and mitosis completed by 4 h (Fig. 1C). However, at the non-permissive temperature, these cells arrested with 2N DNA (Fig. 1C), a large bud and an undivided nucleus. Similar results were obtained with other missense alleles of prp17 (Table 1). Thus, all alleles of prp17 in this experimental regime arrest with 2N DNA and fail to undergo nuclear division. Further, to prove conclusively the requirement for Prp17 beyond S phase initiation, yet another set of experiments was done. Here, prp17::LEU2 cells were synchronized in G1 by alpha-factor treatment and then allowed to resume growth at permissive conditions for 2 h, thereby allowing them to pass Start and initiate S phase. After this time interval, half of the culture was shifted to non-permissive temperature while the other half was maintained at the permissive temperature. In parallel, wild-type cells were subjected to identical experimental conditions. Consistent with results described in the previous sections, prp17::LEU2 cells shifted to non- permissive temperature arrest with 2N DNA (Fig. 1D). Collectively, these experiments clearly demonstrate that Prp17/Cdc40 is required for both the G1/S and G2/M transitions.
###end p 31
###begin title 32
###xml 32 33 32 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
Spindle maintenance defects in G2/M-arrested prp17 cells-tubulin as a target for regulation by splicing
###end title 32
###begin p 33
###xml 32 43 32 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC40/PRP17</italic>
###xml 77 78 77 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c7">7</xref>
###xml 201 206 201 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 674 675 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkg333tb1">1</xref>
###xml 682 687 668 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
Earlier reports have implicated CDC40/PRP17 in spindle assembly/maintenance (7). Since we find allele-specific phenotypes for onset of S phase, we examined the status of the mitotic spindle in various prp17 mutants, with special attention paid to alleles that progress through S phase after Prp17 inactivation. The mitotic spindle in cells that were allowed to resume the division cycle after synchronization with alpha-factor or HU treatment was monitored by indirect immunoflorescence of alpha-tubulin. We find a spindle maintenance defect within 2 h of exposure to 37degreesC (data not shown), and by 3 h cells do not have any spindles or have very short spindles (Table 1). The prp17 alleles differ only in the severity of spindle defects.
###end p 33
###begin p 34
###xml 224 248 217 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 291 295 281 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB2</italic>
###xml 379 383 365 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 388 392 374 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 482 489 468 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-1</italic>
###xml 519 520 505 506 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 694 701 664 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cef1-13</italic>
###xml 710 714 680 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">isy1</italic>
###xml 720 724 686 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">syf2</italic>
###xml 796 797 758 759 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 808 809 770 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c6">6</xref>
###xml 810 812 772 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c26">26</xref>
###xml 224 248 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
We have investigated possible reasons underlying microtubule instability by examining post-transcriptional regulation of tubulin. The spindle consists of microtubules that are polymers of the alpha-beta tubulin heterodimer. Saccharomyces cerevisiae has a single essential beta-tubulin gene, TUB2, which does not contain any introns. There are two functional alpha-tubulin genes, TUB1 and TUB3, which share 90% homology entirely within their coding sequences. In crude extracts from prp17-1 cells passing through S and G2, there is a significant reduction (approximately80%) in alpha-tubulin protein levels when this splicing factor is inactivated (data not shown). Similar effects are known in cef1-13, and in isy1Delta syf2Delta double mutants. These mutations in splicing factors also cause a G2/M arrest (6,26).
###end p 34
###begin p 35
###xml 81 85 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 90 94 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 189 193 185 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 215 218 211 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 276 280 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 455 456 451 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c4">4</xref>
###xml 457 459 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c15">15</xref>
###xml 460 462 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c27">27</xref>
###xml 641 645 637 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 650 654 646 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 1064 1069 1060 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 1074 1079 1070 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp18</italic>
###xml 1184 1188 1180 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 1193 1197 1189 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 1244 1249 1240 1245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp16</italic>
###xml 1251 1255 1247 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">slu7</italic>
###xml 1260 1265 1256 1261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp22</italic>
###xml 1689 1691 1685 1687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c28">28</xref>
###xml 1692 1694 1688 1690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c29">29</xref>
###xml 1725 1730 1721 1726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp22</italic>
###xml 1821 1823 1817 1819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c17">17</xref>
###xml 1830 1836 1826 1832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">psf1-1</italic>
###xml 1849 1853 1845 1849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PRP8</italic>
###xml 1983 1985 1979 1981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c30">30</xref>
###xml 425 430 <span type="species:ncbi:4932">yeast</span>
Consequently, we investigated regulation of alpha-tubulin by mRNA splicing. Both TUB1 and TUB3 genes contain introns that have been speculated targets for regulation by splicing. While the TUB1 intron has consensus cis-recognition elements, it is a small intron (115 nt). The TUB3 intron (298 nt) is unusual in that the distance between the branch point and the 3' splice site is 135 nt, as opposed to 36-43 nt in most other yeast introns. We and others (4,15,27) have hypothesized that Prp17 is required for improving the efficiency of splicing for transcripts with non-canonical intron features. Therefore, the splicing efficiency of both TUB1 and TUB3 pre-mRNAs was examined. Since these genes share extensive nucleotide homology, we devised a semi-quantitative RT-PCR strategy to measure pre-mRNA and mRNA levels for each transcript. As a measure of splicing efficiency, we have determined the decrease in mRNA and also the change in precursor mRNA to mRNA ratio after inactivation of temperature-sensitive mutations in splicing factors. The effects caused by prp17 and prp18 were compared since both are non-essential auxiliary factors for the second step. We have also examined TUB1 and TUB3 splicing in other second-step factor mutants: prp16, slu7 and prp22. Prp16 is an essential helicase required to bring about a critical conformational change at the 3' splice site. It is suggested to act at or about the step of action of Prp17. The contribution of Slu7 and Prp22 to splicing of artificial substrates with varying distances between branch point and 3' splice site has implicated them in the splicing of introns with increased distances between these specific intron elements (28,29). Furthermore, new alleles of prp22 have been identified in a screen for mutants that arrest in mitosis with no microtubules (17). The psf1-1 mutation in PRP8 was also included in this study, since it identifies a Prp8 domain involved in 3' splice site definition during the second step (30).
###end p 35
###begin p 36
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 40 51 40 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 156 160 156 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 216 217 216 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f4">4</xref>
###xml 297 304 297 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-1</italic>
###xml 336 340 336 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 477 488 477 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp18::HIS3</italic>
###xml 490 497 490 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp16-2</italic>
###xml 499 505 499 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">slu7-1</italic>
###xml 507 514 507 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp22-1</italic>
###xml 519 525 519 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">psf1-1</italic>
###xml 540 544 540 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 563 564 563 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f4">4</xref>
###xml 610 615 610 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 640 644 640 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 678 679 678 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f4">4</xref>
###xml 740 745 740 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 813 815 813 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c14">14</xref>
###xml 816 818 816 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c31">31</xref>
###xml 819 821 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c32">32</xref>
###xml 835 840 835 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp18</italic>
###xml 896 900 896 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 923 924 923 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f4">4</xref>
###xml 967 971 967 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 1014 1015 1014 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f4">4</xref>
###xml 1132 1137 1126 1131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp16</italic>
###xml 1142 1147 1136 1141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp22</italic>
###xml 1157 1163 1151 1157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">slu7-1</italic>
###xml 1168 1174 1162 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">psf1-1</italic>
###xml 1202 1206 1196 1200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 1223 1224 1217 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f4">4</xref>
###xml 1355 1359 1349 1353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
The splicing of TUB1 was compromised in prp17::LEU2, as revealed by the drastic decrease in mRNA; this contrasts with the lack of any significant change in TUB1 mRNA levels in similarly treated wild-type cells (Fig. 4A and B). This effect is also observed upon inactivation of the missense mutant prp17-1, confirming that the decreased TUB1 mRNA levels are seen in the absence of active Prp17 at higher temperatures. None of the other mutations in second-step splicing factors prp18::HIS3, prp16-2, slu7-1, prp22-1 and psf1-1 greatly alter TUB1 mRNA levels (Fig. 4A and B). Despite the depleted mRNA levels in prp17 mutants, an increase in TUB1 pre-mRNA is not detectable (Fig. 4A and C). Failure to build up precursors or intermediates in prp17 mutants has been reported for other intron-containing transcripts (14,31,32). We observe prp18 mutations to behave similarly; there is no increase in TUB1 pre-mRNA levels (Fig. 4A and C). Notably there is no reduction in TUB1 mRNA levels in the absence of Prp18 (Fig. 4B). In fact, an increase in mRNA levels is observed at 37degreesC. Strikingly, of the essential second-step factors, prp16 and prp22, but not slu7-1 and psf1-1, cause increased levels of TUB1 pre-mRNAs (Fig. 4A and C). Thus, taking the combined effects of a decrease in mRNA levels and an increase in the pre-mRNA/mRNA ratio, we infer that TUB1 intron splicing requires Prp17, Prp16 and Prp22.
###end p 36
###begin p 37
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 109 113 109 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 235 236 235 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f5">5</xref>
###xml 263 267 263 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 271 282 271 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 326 333 326 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-1</italic>
###xml 347 348 347 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f5">5</xref>
###xml 378 382 378 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 393 397 393 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 425 430 425 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp16</italic>
###xml 435 440 435 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp22</italic>
###xml 465 476 465 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp18::HIS3</italic>
###xml 478 484 478 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">slu7-1</italic>
###xml 489 495 489 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">psf1-1</italic>
###xml 579 583 579 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 588 592 588 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 604 609 604 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PRP17</italic>
###xml 611 616 611 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PRP16</italic>
###xml 621 626 621 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PRP22</italic>
The consequence of mutations in second-step splicing factors for TUB3 intron splicing was also examined. The TUB3 transcripts are poorly spliced in the absence of Prp17, as evidenced by an increase in the precursor/message ratio (Fig. 5A-C). The poor splicing of TUB3 in prp17::LEU2 is replicated in the temperature-sensitive prp17-1 strain (Fig. 5A). Similar to the effects on TUB1 splicing, TUB3 splicing is inefficient in prp16 and prp22 mutants. The effects of prp18::HIS3, slu7-1 and psf1-1 are comparatively lower. Collectively, these data indicate a greater dependence of TUB1 and TUB3 introns on PRP17, PRP16 and PRP22.
###end p 37
###begin title 38
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 84 95 84 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
A second-step defect for the splicing of the TUB3 intron in cell-free extracts from prp17::LEU2
###end title 38
###begin p 39
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 203 210 203 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 237 241 237 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 246 250 246 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 276 284 276 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 302 306 302 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 311 315 311 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 387 395 387 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 425 429 425 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACT1</italic>
###xml 498 506 498 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 511 518 511 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 574 578 574 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 580 584 580 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 589 593 589 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACT1</italic>
###xml 619 627 619 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 836 841 836 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PRP17</italic>
###xml 847 851 847 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACT1</italic>
###xml 959 960 953 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f6">6</xref>
###xml 1025 1026 1019 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f6">6</xref>
###xml 1170 1174 1164 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACT1</italic>
###xml 1225 1236 1219 1230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 1356 1357 1350 1351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f6">6</xref>
###xml 1488 1492 1482 1486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACT1</italic>
###xml 1581 1583 1575 1577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c12">12</xref>
###xml 1717 1725 1711 1719 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1760 1762 1754 1756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c33">33</xref>
###xml 1763 1765 1757 1759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c34">34</xref>
###xml 1788 1792 1782 1786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 1802 1810 1796 1804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1848 1852 1842 1846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACT1</italic>
###xml 1925 1926 1907 1908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f6">6</xref>
###xml 2007 2008 1989 1990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f6">6</xref>
###xml 2021 2032 2003 2014 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 2056 2060 2038 2042 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 2162 2163 2144 2145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f6">6</xref>
###xml 2209 2210 2191 2192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f6">6</xref>
###xml 2241 2245 2223 2227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 2331 2335 2313 2317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 2364 2372 2346 2354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
The reduction in TUB1 and TUB3 spliced mRNA in prp17 cells could arise as an indirect consequence of reduced transcription or altered decay kinetics for these mRNAs. To probe the direct relevance of the in vivo data, the splicing of the TUB1 and TUB3 transcripts was examined in vitro. Segments of the TUB1 and TUB3 genes were cloned as minigenes to generate splicing substrates through in vitro transcription. As a control, ACT1 pre-mRNA was also generated. The latter is spliced efficiently both in vitro and in vivo, and is the prototype in nearly all such analyses. The TUB3, TUB1 and ACT1 substrates were examined in vitro particularly for the kinetics of the second splicing reaction. This was studied in two different cell-free extracts, one from a wild-type strain and the other from an isogenic strain bearing a null allele of PRP17. The ACT1 intron is spliced efficiently in wild-type extracts; products of step 1 appear rapidly at 23degreesC (Fig. 6A, lanes 2-5) and the second step occurs without any delay (Fig. 6B). At any time point, the products from the second step are in larger amounts than those from the first step. In contrast, the splicing of the ACT1 intron is inefficient for step 2 in extracts from prp17::LEU2; products from the second step are at significantly lower levels. This defect persists even at later time points (Fig. 6A, lanes 6-9, and B). These observations reinforce the general requirement for Prp17 for improving the rate of the second step for ACT1 and concur with data obtained through immunodepletion of Prp17 from wild-type extracts (12). The complete absence of Prp17 does not fully abolish the second step, since some mRNA is formed. Similar consequences are noted in in vitro reactions that lack active Prp18 (33,34). The splicing of the TUB3 pre-mRNA in vitro is marginally slow, as compared with ACT1 (approximately10 min delay) for step 1 even in wild-type extracts (Fig. 6C and D). Even more striking is a delay in the kinetics of splicing step 2 (Fig. 6C and D). In prp17::LEU2, the products from the TUB3 substrate are at low levels and a build up of the intermediates from reaction 1 occurs (compare Fig. 6A, lanes 8 and 9 with C, lanes 9 and 10; Fig. 6B and D). This inefficiency of TUB3 splicing is reproducible even in different batches of extracts (data not shown). The TUB1 intron was not spliced from in vitro transcripts even in wild-type extracts, perhaps due to the small intron size and extremely poor splicing efficiency, and therefore could not be investigated further.
###end p 39
###begin p 40
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c34">34</xref>
###xml 264 265 264 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f6">6</xref>
###xml 467 468 467 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 468 469 468 469 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 518 522 518 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACT1</italic>
###xml 559 563 559 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 613 614 613 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkg333tb2">2</xref>
###xml 726 727 726 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkg333tb2">2</xref>
###xml 800 804 800 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
While the splicing reactions have not been modeled kinetically, we have estimated the likely rate of the second step in these reactions, adopting the approximations of Horowitz and Abelson (34). Quantitative analyses of the time course of splicing shown in Figure 6A and B were done to estimate the rate of the second step. The rate of change in mRNA occurring within a 15 min time frame over the concentration of lariat intermediate was taken as an approximation of k2, i.e. the rate of the second splicing reaction. ACT1 is a somewhat better substrate than TUB3 for the second step in wild-type extracts (Table 2). This small difference in the estimated rate of the second step is accentuated in the absence of Prp17 (Table 2), indicating a direct role for this non-essential factor in splicing of TUB3, with its non-standard intron.
###end p 40
###begin title 41
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 9 10 5 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 54 61 50 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-1</italic>
###xml 103 104 99 100 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
TUB1Deltai gene does not rescue the growth defects of prp17-1; multiple splicing targets for Prp17 in G2/M
###end title 41
###begin p 42
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 86 90 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 135 139 135 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 144 145 140 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 255 259 251 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 369 375 365 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tub1-1</italic>
###xml 377 384 373 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-1</italic>
###xml 389 400 385 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 443 447 439 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 452 453 444 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 686 690 671 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB2</italic>
###xml 742 743 724 725 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 747 749 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c35">35</xref>
###xml 756 760 738 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 765 766 743 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 810 816 788 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tub1-1</italic>
###xml 836 840 814 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 845 846 819 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 931 936 905 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 1031 1035 1005 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 1040 1041 1010 1011 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 1083 1090 1053 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-1</italic>
###xml 1095 1106 1065 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 1121 1122 1091 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f7">7</xref>
###xml 1177 1184 1143 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-1</italic>
###xml 1228 1240 1194 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-1 TUB1</italic>
###xml 1245 1246 1207 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 1365 1372 1323 1330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-1</italic>
###xml 1429 1430 1387 1388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f7">7</xref>
###xml 1526 1530 1480 1484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 1535 1536 1485 1486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 1548 1549 1498 1499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f7">7</xref>
###xml 1613 1620 1563 1570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-1</italic>
###xml 1642 1643 1592 1593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f7">7</xref>
###xml 1656 1663 1606 1613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-1</italic>
###xml 1681 1682 1631 1632 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1699 1700 1649 1650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkg333tb1">1</xref>
###xml 1747 1752 1697 1702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 1816 1817 1766 1767 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
A precise deletion of the TUB1 intron was created by a loopout PCR on a plasmid-borne TUB1 gene (Materials and Methods). The resulting TUB1Deltai plasmid was linearized and integrated at its genomic locus so as to generate a single functional copy of the TUB1 gene without the intron. The consequences of this intronless gene were examined in wild-type, cold-sensitive tub1-1, prp17-1 and prp17::LEU2 strains. We resorted to the expression of TUB1Deltai from the endogenous promoter at its chromosomal location since the expression levels and the stoichiometry of alpha-tubulin to beta-tubulin are critical for efficient assembly and maintenance of mitotic spindles. Overexpres sion of TUB2, encoding beta-tubulin, causes a growth arrest at G2/M (35). The TUB1Deltai gene fully rescued the cold sensitivity of tub1-1, demonstrating the TUB1Deltai construct to be functional (data not shown). The instability of mitotic spindles in prp17 mutant strains makes them mildly sensitive to benomyl, a microtubule-depolymerizing drug. The TUB1Deltai construct rescues this phenotype in both prp17-1 and prp17::LEU2 strains (Fig. 7A). We have determined alpha-tubulin protein levels in prp17-1 cells and compared them with the levels in prp17-1 TUB1Deltai. These experiments were performed in synchronized cultures obtained through HU treatment. alpha-Tubulin in the parent prp17-1 cells is observed only at permissive temperatures (Fig. 7B). The inability to generate alpha-tubulin at non-permissive temperatures is alleviated by the TUB1Deltai gene (Fig. 7B). Nevertheless, the temperature-sensitive growth phenotype of prp17-1 is not rescued (Fig. 7C). Notably, prp17-1 displays only a G2/M arrest (Table 1). Taken together, these data indicate that in prp17 mutants, multiple limiting factors affect progression through G2/M.
###end p 42
###begin title 43
DISCUSSION
###end title 43
###begin p 44
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c14">14</xref>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c11">11</xref>
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c12">12</xref>
###xml 306 307 300 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c4">4</xref>
###xml 308 310 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c15">15</xref>
###xml 311 313 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c27">27</xref>
###xml 364 369 358 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 455 456 449 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c7">7</xref>
###xml 457 458 451 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c8">8</xref>
###xml 728 729 722 723 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 737 738 731 732 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 882 889 876 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-1</italic>
###xml 1005 1006 999 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkg333tb1">1</xref>
###xml 1148 1153 1142 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 1223 1224 1217 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkg333tb1">1</xref>
###xml 1363 1364 1357 1358 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1377 1382 1371 1376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 1540 1541 1534 1535 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1626 1627 1620 1621 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1749 1750 1743 1744 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1760 1765 1754 1759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 1810 1811 1804 1805 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1822 1827 1816 1821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 1911 1916 1905 1910 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PRP17</italic>
###xml 1952 1956 1946 1950 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLF1</italic>
###xml 1958 1962 1952 1956 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYF3</italic>
###xml 2058 2060 2052 2054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c36">36</xref>
Earlier experiments have shown Prp17 to be a second-step splicing factor, suggesting a role as a general spliceosome component (14,11,12). However, since cells lacking Prp17 are viable at 23degreesC, it is thought to encode a function auxiliary to an essential, second-step splicing factor, possibly Prp8 (4,15,27). Interestingly, the behavior of a null allele of prp17 implied a role for Prp17/Cdc40 in efficient progression through S phase and mitosis (7,8). It remained unclear if discrete transitions in the cell division cycle require Prp17. In this report, using a null mutant and a number of alleles with missense mutations in different regions of the protein, we demonstrate a requirement for Prp17 particularly during G1/S and G2/M cell cycle transitions. Several other lines of evidence gathered here strongly support this conclusion. Strikingly, even the weakest allele, prp17-1 (with a G127A alteration), fails to complete mitosis; cells arrest with 2N DNA but without mitotic spindles (Table 1). No defect (kinetic or otherwise) for entry into and completion of S phase is detected in this mutant (data not shown). Our data from other prp17 alleles confirm that Prp17 is required for entry into S phase (Table 1). These results strongly suggest a role for this factor at these two distinct cell cycle transitions. One possible reason underlying the G1/S arrest in prp17 mutants may be the inefficient or lack of splicing of several intron-containing transcripts whose products encode factors needed for the metabolic state of G1 cells. The hypothesis is supported by our finding that ectopic overexpression of a G1 cyclin, whose levels are one of the critical elements for transition to S phase, cannot force an S-phase entry in these G1-arrested prp17 cells. The alternative possibility for the G1 arrest in prp17 is a direct role for Prp17 in DNA replication. This is a plausible situation since PRP17 exhibits genetic interactions with CLF1 (SYF3), a splicing factor that recently was shown to interact with replication origin protein, Orc2 (36). Prp17 thus joins a host of factors that influence specific early and late events in the regulated cascade of the cell division cycle. Mechanistically how this might be achieved has been speculated upon and tested to some extent here.
###end p 44
###begin p 45
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PRP17</italic>
###xml 237 242 237 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp22</italic>
###xml 247 252 247 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp16</italic>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c17">17</xref>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c37">37</xref>
###xml 345 349 345 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp8</italic>
###xml 351 355 351 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dbf5</italic>
###xml 388 389 388 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c1">1</xref>
###xml 443 448 443 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp16</italic>
###xml 453 458 453 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp22</italic>
###xml 597 601 593 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 605 609 601 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 741 745 737 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 752 754 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c37">37</xref>
###xml 787 791 783 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 796 800 792 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 835 842 831 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1041 1045 1037 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 1050 1054 1046 1050 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 1085 1090 1081 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PRP17</italic>
###xml 1095 1100 1091 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PRP16</italic>
###xml 1136 1141 1132 1137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PRP16</italic>
###xml 1181 1192 1177 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 1194 1196 1190 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c12">12</xref>
###xml 1208 1216 1204 1212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1357 1359 1353 1355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c12">12</xref>
###xml 1415 1419 1411 1415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 1424 1428 1420 1424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 1629 1633 1625 1629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 1638 1642 1634 1638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 1876 1878 1872 1874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c28">28</xref>
###xml 1907 1911 1903 1907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 1951 1954 1947 1950 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 1968 1972 1964 1968 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 2238 2242 2234 2238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 2333 2335 2329 2331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c31">31</xref>
###xml 2366 2370 2362 2366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 2523 2525 2519 2521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c38">38</xref>
###xml 2310 2315 <span type="species:ncbi:4932">yeast</span>
PRP17 is not the only second-step splicing factor that affects the cell division cycle. Prp8, Slu7, Prp16, Prp18 and Prp22 are other splicing factors whose functions are required for the second step of splicing. Amongst them, alleles of prp22 and prp16 have been uncovered recently in genetic screens for mitosis defects (17,37), and alleles of prp8 (dbf5) have been reported previously (1). The lack of mitotic spindles in the new alleles of prp16 and prp22 lead to the hypothesis that alpha-tubulin transcripts are targets for regulation by splicing. While the contributions of these factors to TUB1 or TUB3 splicing was not investigated, the hypothesis was supported by the rescue of spindle defects in these new strains by an intronless TUB1 gene (37). Our data from the analysis of TUB1 and TUB3 implicate these transcripts to be in vivo substrates dependent on Prp17. By examining the splicing of these transcripts in mutants for several second-step factors, we show that Prp17, Prp16 and Prp22 contribute to the efficient splicing of TUB1 and TUB3. Genetic interactions between PRP17 and PRP16 are known; high copy expression of PRP16 partially rescues the growth defect of prp17::LEU2 (12). Further, in vitro studies implicate that the second step of splicing can be divided into two events where Prp16 and Prp17 act at an early ATP-dependent step (12). Therefore, the similar effects of Prp16 and Prp17 on TUB1 and TUB3 intron splicing that we observe are not surprising. Prp18 and Slu7 are predicted to act in concert in a step subsequent to Prp16 and Prp17. Inactivation of either protein has marginal consequences on TUB1 and TUB3 splicing efficiency, with Prp18, the non-essential factor, perhaps having a somewhat greater role. Slu7 is predicted to be required for splicing of introns where the distance between the branch point and the 3' splice site is >7 nt (28). We find here that despite TUB3 having a 135 nt distance between these cis elements and TUB1 having a 37 nt spacing feature, both of these precursors are spliced in the absence of active Slu7. The lack of dependence on Slu7 is consistent with the marginal role of Prp18, its partner in this step. Our results and predictions for the contribution of Prp18 to TUB3 splicing agree with the data obtained from genome-wide analysis of yeast mRNA processing (31). Any minor role for Prp18 in TUB3 splicing may arise from a recently described new domain in Prp18. The latter contributes to second-step splicing independent of Prp18-Slu7 association (38).
###end p 45
###begin p 46
###xml 8 16 8 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c12">12</xref>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c13">13</xref>
###xml 582 584 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c13">13</xref>
###xml 591 599 591 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 652 657 652 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 800 804 800 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACT1</italic>
###xml 809 813 809 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 827 831 827 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 848 856 848 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 949 952 949 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB</italic>
###xml 957 958 953 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 967 974 963 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-1</italic>
###xml 979 990 975 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 297 302 <span type="species:ncbi:9606">human</span>
Through in vitro splicing reactions, we validate the role of Prp17 in increasing the rate of the second splicing step without being absolutely required for the reaction. Previous analyses have deduced the same through immunodepletion of Prp17 from wild-type extracts (12). It is as yet unknown if human Prp17 behaves similarly. Attempts to deplete hPrp17 from HeLa cell extracts were not successful (13). Nevertheless, hPrp17 associates with spliceosomes prior to the second step, in wild-type substrates and in artificial substrates with greater distances between the BP and 3'ss (13). The in vitro data reported here performed with extracts from the prp17 null strain irrevocably point to its auxilliary role in the second step of splicing. This is the case for at least two different transcripts, ACT1 and TUB3. By studying TUB3 intron splicing in vitro, we show that this substrate is more sensitive to the absence of Prp17. Our analysis of the TUBDeltai gene in prp17-1 and prp17::LEU2 cells suggests other critical limiting components in addition to alpha-tubulin for progression through mitosis.
###end p 46
###begin p 47
###xml 64 75 64 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 108 112 108 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 236 237 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c4">4</xref>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c39">39</xref>
###xml 560 564 560 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 569 573 569 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 621 625 621 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CEF1</italic>
###xml 668 670 668 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c40">40</xref>
###xml 671 673 671 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c41">41</xref>
###xml 708 716 708 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 754 755 754 755 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 764 765 764 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c6">6</xref>
###xml 766 768 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c42">42</xref>
###xml 791 795 791 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CEF1</italic>
###xml 799 804 799 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PRP17</italic>
We observe a partial reduction in the first step of splicing in prp17::LEU2 extracts, particularly with the TUB3 substrate. The genetic interaction between Prp17 and factors in the Prp19-associated complex may explain this observation (4). Prp19 and associated proteins act early during spliceosome assembly, at or around the time of loading U4/U6 onto the spliceosome (39). In the absence of Prp17, this step may be inefficient. Perhaps events leading from the association of Prp19 with the spliceosome to the second-step function of Prp22 are compromised in TUB1 and TUB3 in the absence of Prp17. In fact, depletion of CEF1, a component of Prp19-associated complex (40,41), blocked both splicing reactions in vitro, and its genetic depletion causes a G2 arrest (6,42). The precise role of CEF1 or PRP17 is not clear. Collectively, our results, together with the other recent studies discussed here, suggest that multiple interactions of Prp17 with other essential splicing factors such as Prp16 or Prp22 improve the second step of the splicing reaction. Our data provide clues to the nature of the involvement of the pre-mRNA splicing apparatus in cell cycle progression.
###end p 47
###begin title 48
Figures and Tables
###end title 48
###begin p 49
###xml 24 25 24 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 33 34 33 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 82 93 82 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 319 330 313 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 333 334 327 328 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 368 379 362 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 454 455 436 437 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 478 479 460 461 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 493 504 475 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 779 780 745 746 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 782 793 748 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 969 970 923 924 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 973 974 927 928 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 988 999 942 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
 Prp17 is required for G1/S and G2/M transitions. FACS analysis of DNA content in prp17::LEU2 cells assayed in various arrest/release protocols. The peaks representing 1N or 2N DNA content are labeled. Indicated to the right of each data plot are the time points shown here. CYC denotes a 23degreesC cycling culture of prp17::LEU2. (A) Terminal arrest phenotypes in a prp17::LEU2 culture grown at 23degreesC and shifted to 37degreesC at time point 0 h. (B) Arrest phenotype in G1-synchronized prp17::LEU2 cells grown at non-permissive temperatures. alpha-Factor-treated cells were released at time 0 h to either permissive (23degreesC, left) or non-permissive temperatures (37degreesC, right). Plots show cellular DNA content in aliquots withdrawn at the indicated time points. (C) prp17::LEU2 cells grown at 23degreesC were synchronized in early S phase with hydroxyurea (time point 0 h). Cells were then released to 23 and 37degreesC, and DNA content was monitored. (D) G1-synchronized prp17::LEU2 cells were generated as in (B). These cells were first released for growth at 23degreesC for 2 h. At this stage, marked time point 0 h, half the culture was shifted to 37degreesC. DNA content in cells withdrawn subsequently at 2, 4 and 6 h is plotted.
###end p 49
###begin p 50
###xml 25 26 25 26 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 67 78 67 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 87 88 87 88 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 98 109 98 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 327 328 321 322 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 355 359 349 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLB5</italic>
###xml 375 386 369 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 444 445 438 439 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 496 506 490 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLB5/ SNR7</italic>
###xml 601 602 595 596 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 625 629 619 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNR1</italic>
###xml 645 656 639 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 724 725 718 719 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 790 794 784 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNR1</italic>
###xml 843 844 837 838 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 876 880 870 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN1</italic>
###xml 897 898 891 892 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 921 925 915 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN1</italic>
###xml 958 964 952 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNR189</italic>
###xml 1031 1035 1025 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN1</italic>
###xml 1036 1042 1030 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNR189</italic>
 Transcript levels of a G1 cyclin and two Start-dependent genes in prp17::LEU2 cells. G1-arrested prp17::LEU2 cells were released to fresh medium at 23 or 37degreesC. Total RNA in samples withdrawn at regular intervals from both cultures was analyzed by northern blots. The lane marked CYC denotes RNA from a cycling culture. (A) Changes in the levels of CLB5 transcripts as prp17::LEU2 cells progress through the cell cycle upon release from G1 synchronization. The bar graph plots the ratio of CLB5/ SNR7 at the various time points tested in cultures at permissive and non-permissive temperatures. (B) Changes in levels of RNR1 transcripts as prp17::LEU2 cells progress through the cell division cycle after release from G1 synchronization. The bar graphs depict the normalized levels of RNR1 at these different time points and conditions. (C) The blot was probed to detect CLN1 transcripts, a G1 cyclin. The levels of CLN1 mRNA were normalized to that of SNR189, a constitutively expressed RNA. The bar graph plots the ratio of CLN1/SNR189 at the various time points tested.
###end p 50
###begin p 51
###xml 2 3 2 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 99 103 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN2</italic>
###xml 119 120 119 120 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 130 141 130 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 183 184 183 184 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 192 196 192 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN2</italic>
###xml 219 223 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3</italic>
###xml 233 244 233 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 419 423 415 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN2</italic>
###xml 571 572 557 558 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
 (A) A schematic representation of the experimental strategy used to assess the effects of ectopic CLN2 expression on G1-arrested prp17::LEU2 cells. A galactose-inducible version of G1 cyclin CLN2 was integrated at the URA3 locus in prp17::LEU2 cells. The cells were grown in non-inducing conditions and treated with alpha-factor for 2-3 h, following which an aliquot of the culture received galactose for induction of CLN2. After complete synchronization, both cultures were released from alpha-factor arrest and tested for cell cycle progression at 23 and 37degreesC. (B) The DNA content as determined by FACS analysis in the four cultures is plotted. The growth conditions and time point of analysis are shown on the right.
###end p 51
###begin p 52
###xml 2 3 2 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 425 428 425 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 459 463 459 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNR7</italic>
###xml 629 630 629 630 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 760 761 754 755 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 798 802 792 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
 (A) RT-PCR analysis to measure changes in TUB1 intron splicing after temperature-dependent inactivation of mutant second-step splicing factors. cDNA was generated using RNA from each strain, grown at permissive temperatures or after shift to non-permissive temperatures for 60 min. The RT-PCR products corresponding to the spliced mRNA and the unspliced precursor are indicated to the right. The lane M indicates the pBR322 HinfI markers used. The U5 snRNA (SNR7) levels were measured concurrently to provide a normalization control since it does not contain an intron. These cDNAs were quantitated by phosphorimager analysis. (B) The bar graphs plotted depict the fold decrease in normalized mRNA levels that occur in each strain after shift to 37degreesC. (C) The bar graphs show the normalized TUB1 pre-mRNA/mRNA ratio at 23degreesC or after shift to 37degreesC in each of the strains.
###end p 52
###begin p 53
###xml 2 3 2 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 140 144 140 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 198 199 198 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg333f4">4</xref>
###xml 344 345 344 345 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 379 383 379 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 463 464 463 464 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 489 493 489 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
 (A) RT-PCR analysis of TUB3 splicing efficiency in mutants of second-step splicing factors. Reverse transcription with primers specific to TUB3 was performed on the same RNA as that used in Figure 4. These RNAs were quantitated by phosphorimager analysis, following which the mRNA and the pre-mRNA values were normalized to that of U5 snRNA. (B) The fold decrease in normalized TUB3 mRNA levels occurring in each mutant after temperature inactivation is shown. (C) The ratio of unspliced TUB3 pre-mRNA to mRNA in each strain grown at permissive temperature or after shift to non-permissive conditions is plotted.
###end p 53
###begin p 54
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACT1</italic>
###xml 30 34 30 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 52 63 52 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 75 76 75 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 78 80 78 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 90 94 90 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACT1</italic>
###xml 423 427 417 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACT1</italic>
###xml 456 467 450 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 492 493 486 487 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 495 497 489 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 507 511 501 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 569 580 563 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 780 781 774 775 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 786 787 780 781 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 854 858 848 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACT1</italic>
###xml 866 870 860 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
###xml 960 971 954 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
In vitro splicing of ACT1 and TUB3 in wild-type and prp17::LEU2 extracts. (A) 32P-labeled ACT1 pre-mRNA was reacted with a wild-type extract at 23degreesC. Aliquots were withdrawn at the time points given above each lane (lanes 2-5). The RNA products were analyzed by denaturing PAGE. The RNA species lariat-exon 2, lariat intron, precursor, mRNA and exon 1 are indicated to the right. The splicing reaction performed with ACT1 substrate and extracts from prp17::LEU2 were run on lanes 6-9. (C) 32P-labeled TUB3 pre-mRNA substrate reacted with wild-type (lanes 2-5) or prp17::LEU2 extract (lanes 7-10). The reaction aliquots were withdrawn at the time points given above each lane. The RNA species were resolved on denaturing PAGE and are represented schematically on the right. (B and D) Quantitation of the splicing reactions 1 and 2 for the substrate ACT1 (B) or TUB3 (D). In each case, quantitations were done for reactions with wild-type extract and also prp17::LEU2 extracts. Open bars indicate the amounts of lariat-exon 2 plus exon 1 resulting from reaction 1 at the given time point. Filled-in bars indicate the amounts of lariat intron plus mRNA resulting from reactions 1 and 2 at the given time point. The quantitations of pre-mRNA, lariat-exon 2, lariat intron, mRNA and exon 1 were obtained through phosphorimager analysis of the gels. The levels of the RNA intermediates and product RNAs were normalized to the levels of precursor RNA in each lane.
###end p 54
###begin p 55
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 51 52 47 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 71 78 67 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-1</italic>
###xml 83 94 79 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 97 98 93 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 123 135 119 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17:: LEU2</italic>
###xml 140 147 136 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-1</italic>
###xml 165 169 161 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 174 175 166 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 253 264 239 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
###xml 268 284 254 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2 TUB1</italic>
###xml 289 290 271 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 480 487 462 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-1</italic>
###xml 492 504 474 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-1 TUB1</italic>
###xml 509 510 487 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 519 520 497 498 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 584 591 558 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-1</italic>
###xml 614 626 588 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-1 TUB1</italic>
###xml 631 632 601 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 933 934 887 888 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 970 975 924 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 1000 1004 954 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB1</italic>
###xml 1009 1010 959 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 1172 1179 1122 1129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17-1</italic>
###xml 1183 1194 1133 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17::LEU2</italic>
 Consequences of an intronless TUB1 gene (TUB1Deltai) on phenotypes of prp17-1 and prp17::LEU2. (A) Benomyl sensitivity of prp17:: LEU2 and prp17-1; their rescue by TUB1Deltai. The panels on the left show the growth at 23degreesC of serial dilutions of prp17::LEU2 or prp17::LEU2 TUB1Deltai cultures. The growth of the cells in the absence or presence of benomyl at varying concentrations (indicated on the top) is shown. The panels on the right are from similar experiments with prp17-1 and prp17-1 TUB1Deltai cells. (B) Western blot of alpha-tubulin protein levels. HU-synchronized prp17-1 cells (left panel) or prp17-1 TUB1Deltai cells (right panel) were released at time 0 h to either permissive (23degreesC) or non-permissive temperatures (37degreesC). alpha-Tubulin protein levels in aliquots withdrawn subsequently at the indicated time points are shown here. Clathrin light chain protein levels served as a loading control. (C) Growth at various temperatures of prp17 mutants with or without TUB1Deltai. Serial dilutions of cells of the genotype indicated at the bottom were grown at the temperatures given at the top of each plate. The temperature sensitivity of prp17-1 or prp17::LEU2 is not rescued.
###end p 55
###begin title 56
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">prp17</italic>
###xml 67 68 67 68 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
Summary of cell cycle phenotypes in prp17 mutants synchronized in G1 or early S phase
###end title 56
###begin p 57
ND, not defined.
###end p 57
###begin p 58
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 13 18 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 21 22 21 22 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c7">7</xref>
aSee Vaisman et al. (7).
###end p 58
###begin title 59
###xml 10 18 10 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACT1</italic>
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB3</italic>
Estimated in vitro rate constants for second step with ACT1 and TUB3 substrates
###end title 59
###begin p 60
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 18 19 10 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 35 36 15 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 60 62 40 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg333c34">34</xref>
aDelta[mRNA]/Deltat approximately k2 [lariat intermediate] (34).
###end p 60
###begin title 61
REFERENCES
###end title 61

